What is BTIG's price target for TMCI?

BTIG's latest stated price target for Treace Medical Concepts Inc. (TMCI) is $16, from its action on Feb 4, 2025.

What is BTIG's rating on TMCI?

BTIG rates TMCI Neutral, a neutral rating, as of Nov 7, 2025.

When did BTIG last change its view on TMCI?

On Nov 7, 2025, BTIG downgrades to Neutral from Buy.

BTIG TMCI price target and rating history

Treace Medical Concepts Inc. (TMCI) · Health Care

BTIG rates Treace Medical Concepts Inc. (TMCI) Neutral with a $16 price target, as of its latest action on Nov 7, 2025. It has published 4 rating actions on TMCI since May 2022, including 1 upgrade and 2 downgrades.

Current rating: Neutral
Price target: $16
Median target, all firms: Too few
Actions on TMCI: 4

BTIG price target on TMCI

BTIG price target on TMCI, each point a stated target, May 2022 to February 2025.

Every BTIG rating on TMCI

Nov 7, 2025
DowngradeBTIG downgrades to Neutral from Buy
Feb 4, 2025
UpgradeBTIG upgrades to Buy from Neutral, price target $16
May 8, 2024
DowngradeBTIG downgrades to Neutral from Buy
May 12, 2022
InitiateBTIG starts coverage at Buy, price target $22

Questions about BTIG and TMCI

What is BTIG's price target for TMCI?: BTIG's latest stated price target for Treace Medical Concepts Inc. (TMCI) is $16, from its action on Feb 4, 2025.
What is BTIG's rating on TMCI?: BTIG rates TMCI Neutral, a neutral rating, as of Nov 7, 2025.
When did BTIG last change its view on TMCI?: On Nov 7, 2025, BTIG downgrades to Neutral from Buy.

More TMCI rating histories

Morgan Stanley3

All BTIG ratings TMCI news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.